Literature DB >> 2136152

Morphologic changes in cerebral arteries after subarachnoid hemorrhage.

M R Mayberg1, T Okada, D H Bark.   

Abstract

The premise of this article is that morphologic changes observed in cerebral arteries after subarachnoid hemorrhage play an important role in the pathogenesis of associated ischemic deficits observed in this disorder. Secondly, the arteriopathic response of cerebral arteries to subarachnoid blood is similar in many respects to that observed in systemic vessels under various pathologic conditions, and common pathogenic mechanisms may exist. The data supporting these premises may be summarized as follows: 1. Morphologic changes in human and animal cerebral arteries after subarachnoid hemorrhage are temporally associated with angiographic and clinically significant vasospasm. 2. Profound morphologic changes in cerebral arteries after subarachnoid hemorrhage do not contribute to structural narrowing of the lumen through increases in vessel wall mass. Nevertheless, structural changes may act in concert with contractile mechanisms to alter normal physiologic responses and maintain a narrowed lumen. 3. The agent responsible for arterial narrowing and morphologic changes in cerebral arteries after subarachnoid hemorrhage is contained in the erythrocyte component of whole blood and is most likely hemoglobin. 4. The volume and duration of exposure of subarachnoid blood to the artery appears to be significant in the development of the angiopathic response. 5. Ultrastructural abnormalities in systemic vessels associated with hypertension, atherogenesis, and endothelial damage are similar in many respects to those seen after subarachnoid hemorrhage.

Entities:  

Mesh:

Year:  1990        PMID: 2136152

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  8 in total

Review 1.  Neuroprotection in subarachnoid hemorrhage.

Authors:  Daniel T Laskowitz; Brad J Kolls
Journal:  Stroke       Date:  2010-10       Impact factor: 7.914

Review 2.  Current options for the management of aneurysmal subarachnoid hemorrhage-induced cerebral vasospasm: a comprehensive review of the literature.

Authors:  Guilherme Dabus; Raul G Nogueira
Journal:  Interv Neurol       Date:  2013-10

3.  Role of vascular mitogens in subarachnoid hemorrhage-associated cerebral vasculopathy.

Authors:  Cheryl A Miller; Frederick W Lombard; Ching-Tang Wu; Cory J Hubbard; Lydia Silbajoris; Cecil O Borel; Laura E Niklason
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

4.  Biochemomechanics of cerebral vasospasm and its resolution: I. A new hypothesis and theoretical framework.

Authors:  J D Humphrey; S Baek; L E Niklason
Journal:  Ann Biomed Eng       Date:  2007-05-09       Impact factor: 3.934

5.  Morphometric and ultrastructural analysis of the effect of bromocriptine and cyclosporine on the vasospastic femoral artery of rats.

Authors:  Mehmet Tokmak; Kahan Başocak; Hüseyin Canaz; Gökhan Canaz; Celal İplikçioğlu
Journal:  Int J Clin Exp Med       Date:  2015-10-15

6.  Diabetes mellitus increases risk of vasospasm following aneurysmal subarachnoid hemorrhage independent of glycemic control.

Authors:  Travis Dumont; Anand Rughani; Jeremy Silver; Bruce I Tranmer
Journal:  Neurocrit Care       Date:  2009-05-27       Impact factor: 3.210

7.  Preventive effect of intracisternal heparin for proliferative angiopathy after experimental subarachnoid haemorrhage in rats.

Authors:  I H Tekkök; S Tekkök; O E Ozcan; T Erbengi; A Erbengi
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

8.  Cerebral vasospasm pharmacological treatment: an update.

Authors:  Ioannis Siasios; Eftychia Z Kapsalaki; Kostas N Fountas
Journal:  Neurol Res Int       Date:  2013-01-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.